Children with difficult asthma: A practical approach

Journal of Asthma

Volumn 38, Issue 3, 2001, Pages 189-203

  Payne, Donald N R ^a   Balfour Lynn, Ian M ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Asthma; Pediatric

Indexed keywords

ALLERGEN; AURANOFIN; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOSPORIN; FLUTICASONE; IMMUNOGLOBULIN G; METHOTREXATE; MONTELUKAST; PHOSPHODIESTERASE INHIBITOR; PREDNISOLONE; PREDNISONE; SALBUTAMOL; TERBUTALINE; TROLEANDOMYCIN; ZAFIRLUKAST; ZILEUTON;

ALGORITHM; ASEPTIC MENINGITIS; ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHOMALACIA; CLINICAL EXAMINATION; CLINICAL TRIAL; COMORBIDITY; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; HEART PALPITATION; HUMAN; IMMUNE DEFICIENCY; LARYNX DISORDER; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; TRACHEOMALACIA; TREMOR;

ADMINISTRATION, INHALATION; ALGORITHMS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOTRIENE ANTAGONISTS; STEROIDS; TREATMENT FAILURE;

EID: 0035006969     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-100000106     Document Type: Review

References (113)

1. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, National Heart, Lung, and Blood Institute: Bethesda, MD, 1997.
2. The British Thoracic Society, the National Asthma. Campaign, the Royal College of Physicians of London in Association with the General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society, and the Royal College of Paediatrics and Child Health. The British Guidelines on Asthma Management 1995 Review and Position Statement. Thorax 1997, 52, S1-S21.
3. ERS Taskforce on Difficult/Therapy-Resistant Asthma. Difficult/Therapy-Resistant Asthma: The Need for an Integrated Approach to Define Clinical Phenotypes, Evaluate Risk Factors, Understand Pathophysiology and Find Novel Therapies. Eur. Respir. J. 1999, 13, 1198-1208.
4. Buist, S.A. Cost-Effectiveness of Asthma Management Strategies. Eur. Resp. Rev. 1995, 5, 292-294.
5. Sly, P.D. Lung Function. In Childhood Asthma and Other Wheezing Disorders; Silverman, M., Ed.; Chapman and Hall Medical: London; 1995; 115-139.
6. 1 vs Peak Flow. Lancet 1992, 340, 85-86.
7. Hutchinson, A.A.; Erben, A.; McLennan, L.A.; et al. Intra-Subject Variability of Pulmonary Function Testing in Healthy Children. Thorax 1981, 36, 370-377.
8. Waalkens, H.J.; Merkus, P.J.F.M.; van Essen-Zandvliet. E.E.M.; et al. Assessment of Bronchodilator Response in Children with Asthma. Eur. Resp. J. 1993, 6, 645-651.
9. Payne, D.N.R.; Lincoln, C.; Bush, A. Right-Sided Aortic Arch in Children with Persistent Respiratory Symptoms. Br. Med. J., in press.
10. Peters, F.T.M.; Kleibeuker, J.H.; Postma, D.S. Gastric Asthma: A Pathophysiological Entity? Scand. J. Gastroenterol. 1997, 33 (Suppl. 225), 19-23.
11. Ekstrom, T.; Tibbling, L. Gastro-Oesophageal Reflux and Triggering of Bronchial Asthma: A Negative Report. Eur. J. Resp. Dis. 1987, 71, 177-180.
12. Wilson, N.M.; Charette, L.; Thomson, A.H.; et al. Gastro-Oesophageal Reflux and Childhood Asthma: The Acid Test. Thorax 1985, 40, 592-570.
13. Hampton, F.J.; MacFayden, U.M.; Beardsmore, C.S.; et al. Gastro-Oesophageal Reflux and Respiratory Function in Infants with Respiratory Symptoms. Arch. Dis. Child. 1991, 66, 848-853.
14. Washington, N.; Spensley, P.J.; Smith, C.A.; et al. Dual pH Probe Monitoring Versus Single pH Probe Monitoring in Infants on Milk Feeds: The Impact on Diagnosis. Arch. Dis. Child. 1999, 81, 309-312.
15. Malfgroot, A.; Giocoli, M.; Dab, I. Respiratory Complications of Gastro-Oesophageal Reflux in Children: Asthma Versus Recurrent Infections. In Diseases of the Esophagus, Vol II: Benign Diseases; Little, A.G., Ferguson, M.K., Skinner, D.B. Eds.; Futura Publishing Company: location, 1990; 127-137.
16. Field, S.K.; Gelfand, G.A.; McFadden, S.D. The Effects of Anti-Reflux Surgery on Asthmatics with Gastroesophageal Reflux. Chest 1999, 116, 766-774.
17. Wood, R.P.; Milgrom, H. Vocal Cord Dysfunction. J. Allergy Clin. Immunol. 1996, 98, 481-485.
18. Goldman, J.; Muers, M. Vocal Cord Dysfunction and Wheezing. Thorax 1991, 46, 401-404.
19. Crowley, S.; Goldberg, D.; Argent, A.; et al. Discordant Noises in Children with Asthma. Clinical Child Psychology and Psychiatry 1998, 3, 613-619.
20. Newman, K.B.; Mason, U.G.; Schmaling, K.B. Clinical Features of Vocal Cord Dysfunction. Am. J. Resp. Crit. Care Med. 1995, 152, 1382-1386.
21. Balfour-Lynn, I.M. Difficult Asthma: Beyond the Guidelines. Arch. Dis. Child. 1999, 80, 201-206.
22. Cockcroft, D.W.; Swystun, V.A. Asthma Control Versus Asthma Severity. J. Allergy Clin. Immunol. 1996, 98, 1016-1018.
23. Verschelden, P.; Cartier, A.; L'Archeveque, J.; et al. Compliance with and Accuracy of Daily Self-Assessment of Peak Expiratory Flows in Asthmatic Subjects over a Three Month Period. Eur. Respir. J. 1996, 9, 880-885.
24. Redline, S.; Wright, E.C.; Kattan, M.; et al. Short-Term Compliance with Peak-Flow Monitoring: Results from a Study of Inner City Children with Asthma. Ped. Pulmonol. 1996, 21, 203-210.
25. Bijl-Hofland, I.D.; Cloosterman, S.G.M.; Folgering, H.T.M.; et al. Relation of the Perception of Airway Obstruction to the Severity of Asthma. Thorax 1999, 54, 15-19.
26. Nguyen, B.-P.; Wilson S.R.; German, D.F. Patients' Perceptions Compared with Objective Ratings of Asthma Severity. Ann. Allergy Asthma Immunol. 1996, 77, 209-215.
27. Bisgaard, H. Delivery of Inhaled Medication to Children. J. Asthma 1997, 34, 443-467.
28. Pedersen, S.; O'Byrne, P. A Comparison of the Efficacy and Safety of Inhaled Corticosteroids in Asthma. Allergy 1997, 52 (Suppl. 52), 1-34.
29. Chylack, L.T. Cataracts and Inhaled Corticosteroids. N. Engl. J. Med. 1997, 337, 47-48.
30. Meijer, R.J.; Kerstjens, H.A.M.; Arends, L.R.; et al. Effects of Inhaled Fluticasone and Oral Prednisolone on Clinical and Inflammatory Parameters in Patients with Asthma. Thorax 1999, 54, 894-899.
31. Leung, D.Y.M.; Szefler, S.J. New Insights into Steroid Resistant Asthma. Pediatr. Allergy Immunol. 1998, 9, 3-12.
32. Payne, D.N.R.; Hubbard, M.; McKenzie, S.A. Corticosteroid Unresponsiveness in Asthma: Primary or Acquired? Pediatr. Pulmonol. 1998, 25, 59-61.
33. Custovic, A.; Woodcock, A. Allergen Avoidance. Br. J. Hosp. Med. 1996, 56, 409-412.
34. Eggleston, P.A.; Wood, R.A.; Rand, C.; et al. Removal of Cockroach Allergen from Inner City Homes. J. Allergy Clin. Immunol. 1999, 104, 842-846.
35. Wood, R.A.; Chapman M.D.; Adkinson, N.F.; et al. The Effect of Cat Removal on Allergen Content in Household-Dust Samples. J. Allergy Clin. Immunol. 1989, 83, 730-734.
36. Ronchetti, R.; Macri, F.; Ciofetta, G.; et al. Increased Serum Immunoglobulin E and Increased Prevalence of Eosinophilia in Nine Year Old Children of Smoking Parents. J. Allergy Clin. Immunol. 1990, 86, 400-407.
37. Ronchetti, R.; Bonci, E.; Cutrera, R.; et al. Enhanced Allergic Sensitisation Related to Parental Smoking. Arch. Dis. Child. 1992, 67, 496-500.
38. Martinez, F.; Antognoni, G.; Macri, F.; et al. Parental Smoking Enhances Bronchial Responsiveness in Nine Year Old Children. Am. Rev. Resp. Dis. 1988, 138, 518-523.
39. Murray, A.B.; Morrison, B.J. The Effect of Cigarette Smoke from Mother on Bronchial Responsiveness and Severity of Symptoms in Children with Asthma. J. Allergy Clin. Immunol. 1986, 77, 575-581.
40. Irvine, L.; Crombie, I.K.; Clark, R.A.; et al. Advising Parents of Asthmatic Children on Passive Smoking: Randomised Controlled Trial. Br. Med. J. 1999, 318, 1456-1459.
41. Jonasson, G.; Carlsen, K.-H.; Sodal, A.; et al. Patient Compliance in a Clinical Trial with Inhaled Budesonide in Children with Mild Asthma. Eur. Respir. J. 1999, 14, 150-154.
42. Milgrom, H.; Bender, B.; Ackerson, L.; et al. Noncompliance and Treatment Failure in Children with Asthma. J. Allergy Clin. Immunol. 1996, 98, 1051-1057.
43. Tashkin, D.P. Microelectronic Adherence Monitors for Metered-Dose Inhalers: Who Monitors the Monitors? J. Allergy Clin. Immunol. 1999, 104, 22-24.
44. Koocher, G.; McGrath, M.; Gudas, L. Typologies of Non-Adherence in Cystic Fibrosis. J. Dev. Behav. Paediatr. 1990, 11, 353-358.
45. Richards, D.G.; Mein, E.A.; Nelson, C.D. Chiropractic Manipulation for Childhood Asthma. N. Engl. J. Med. 1999, 340, 391-392.
46. Lane, D.J.; Lane, T.V. Alternative and Complementary Medicine for Asthma. Thorax 1991, 46, 787-797.
47. Bowler, S.D.; Green, A.; Mitchell, C.A. Buteyko Breathing Techniques in Asthma: A Blinded Randomised Controlled Trial. Med. J. Aust. 1998, 169, 575-578.
48. Lask, B. Psychological Factors. In Childhood Asthma and Other Wheezing Disorders; Silverman, M., Ed.; Chapman and Hall Medical: London; 1995; 421-428.
49. Lask, B. Psychological Treatments for Childhood Asthma. Arch. Dis. Child. 1992, 67, 891.
50. Piacentini, G.L.; Bodini, A.; Costella, S.; et al. Exhaled Nitric Oxide and Sputum Eosinophil Markers of Inflammation in Asthmatic Children. Eur. Respir. J. 1999, 13, 1386-1390.
51. Mattes, J.; Storm van's Gravesande, K.; Reining, U.; et al. Nitric Oxide in Exhaled Air is Correlated with Markers of Eosinophilic Airway Inflammation in Corticosteroid-Dependent Childhood Asthma. Eur. Respir. J. 1999, 13, 1391-1395.
52. Byrnes, C.A.; Dinarevic, S.; Shinebourne, E.A.; et al. Exhaled Nitric Oxide Measurements in Normal and Asthmatic Children. Ped. Pulmonol. 1997, 24, 312-318.
53. Kharitonov, S.A.; Yates, D.H.; Robbins, R.A.; et al. Increased Nitric Oxide in Exhaled Air of Asthmatic Patients. Lancet 1994, 343, 133-135.
54. Kharitinov, S.A.; Yates, D.H.; Chung, K.F.; et al. Changes in the Dose of Inhaled Steroid Affects Exhaled Nitric Oxide Levels in Asthmatic Patients. Eur. Respir. J. 1996, 9, 196-201.
55. Stirling, R.G.; Kharitonov, S.A.; Campbell, D.; et al. Increase in Exhaled Nitric Oxide Levels in Patients with Difficult Asthma and Correlation with Symptoms and Disease Severity Despite Treatment with Oral and Inhaled Corticosteroids. Thorax 1998, 53, 1030-1034.
56. Wenzel, S.E.; Szefler, S.J.; Leung, D.Y.M.; et al. Bronchoscopic Evaluation of Severe Asthma: Persistent Inflammation Associated with High Dose Glucocorticoids. Am. J. Respir. Crit. Care Med. 1997, 156, 737-743.
57. Vrugt, B.; Wilson, S.; Underwood, J.; et al. Mucosal Inflammation in Severe Glucocorticoid Dependent Asthma. Eur. Respir. J. 1999, 13, 1245-1252.
58. Wenzel, S.E.; Schwartz, L.B.; Langmack, E.L.; et al. Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics. Am. J. Respir. Crit. Care Med. 1999, 160, 1001-1008.
59. Pavord, I.D.; Brightling, C.E.; Woltmann, G.; et al. Non-Eosinophilic Corticosteroid Unresponsive Asthma. Lancet 1999, 353, 2213-2214.
60. Hoskins, G.; McCowan, C.; Neville, R.G.; et al. Risk Factors and Costs Associated with an Asthma Attack. Thorax 2000, 55, 19-24.
61. Llangovan, P.; Pedersen, S.; Godfrey, S.; et al. Treatment of Severe Steroid Dependent Preschool Asthma with Nebulised Budesonide Suspension. Arch. Dis. Child. 1993, 68, 356-359.
62. Bisgaard, H.; Nikander, K.; Munch, E. Comparative Study of Budesonide as a Nebulized Suspension vs Pressurized Metered-Dose Inhaler in Adult Asthmatics. Resp. Med. 1998, 92, 44-49.
63. Higenbottam, T.W.; Clark, R.A.; Luksza, A.R.; et al. The Role of Nebulised Budesonide in Permitting a Reduction in the Dose of Oral Steroid in Persistent Severe Asthma. Eur. J. Clin. Res. 1994, 5, 1-10.
64. Westbroek, J.; Saarelainen, S.; Laher, M.; et al. Oral Steroid-Sparing Effect of Two Doses of Nebulised Fluticasone Propionate and Placebo in Patients with Severe Chronic Asthma. Respir. Med. 1999, 93, 689-699.
65. Horwitz, R.J.; McGill, K.A.; Busse, W.W. The Role of Leukotriene Modifiers in the Treatment of Asthma. Am. J. Resp. Crit. Care Med. 1998, 157, 1363-1371.
66. Krawiec, M.E.; Wenzel, S.E. Use of Leukotriene Antagonists in Childhood Asthma. Curr. Opin. Pediatr. 1999, 11, 540-547.
67. Knorr, B.; Matz, J.; Bernstein, J.A.; et al. Montelukast for Chronic Asthma in 6-to 14-Year-Old Children: A Randomized, Double-Blind Trial. Pediatric Montelukast Study Group. JAMA 1998, 279, 1181-1186.
68. Kemp, J.P.; Dockhorn, R.J.; Shapiro, G.G.; et al. Montelukast Once Daily Inhibits Exercise-Induced Bronchoconstriction in 6-14 Year Old Children with Asthma. J. Pediatr. 1998, 133, 424-428.
69. Adkins, J.C.; Brogden, R.N. Zafirlukast: A Review of Its Pharmacology and Therapeutic Potential in the Management of Asthma. Drugs 1998, 55, 121-144.
70. Pearlman, D.S.; Ostrom, N.K.; Bronsky, E.A.; et al. The Leukotriene D4-Receptor Antagonist Zafirlukast Attenuates Exercise-Induced Bronchoconstriction in Children. J. Pediatr. 1999, 134, 273-279.
71. Lofdahl, C.-G.; Reis, T.F.; Leff, J.A.; et al. Randomised, Placebo Controlled Trial of Effect of a Leukotriene Receptor Antagonist, Montelukast, on Tapering Inhaled Corticosteroids in Asthmatic Patients. Br. Med. J. 1999, 319, 87-90.
72. Alexander, A.G.; Barnes, N.C.; Kay, A.B. Trial of Cyclosporin in Corticosteroid-Dependent Chronic Severe Asthma. Lancet 1992, 339, 324-328.
73. Lock, S.H.; Kay, A.B.; Barnes, N.C. Double Blind Placebo Controlled Study of Cyclosporin A as a Corticosteroid-Sparing Agent in Corticosteroid-Dependent Asthma. Am. J. Resp. Crit. Care Med. 1996, 153, 509-514.
74. Coren, M.E.; Rosenthal, M.; Bush, A. The Use of Cyclosporin in Corticosteroid Dependent Asthma. Arch. Dis. Child. 1997, 77, 522-523.
75. O'Driscoll, B.R.C.; Ruffles, S.P.; Ayres, J.G.; et al. Long Term Treatment of Severe Asthma with Subcutaneous Terbutaline. Br. J. Dis. Chest 1988, 82, 360-367.
76. Cluzel, M.; Bousquet, J.; Daures, J.P.; et al. Ambulatory Long-Term Subcutaneous Salbutamol Infusion in Chronic Servere Asthma. J. Allergy Clin. Immunol. 1990, 85, 599-605.
77. 2-Agonists in Infantile Asthma. Peditar. Pulmonol. 1992, 12, 81-83.
78. Ayres, J.G.; Miles, J.F.; Barnes, P.J. Brittle Asthma. Thorax 1998, 53, 315-321.
79. Mazer, B.D.; Gelfand, E.W. An Open-Label Study of High-Dose Intravenous Immunoglobulin in Severe Childhood Asthma. J. Allergy Clin. Immunol. 1991, 87, 976-983.
80. Jakobsson, T.; Croner, S.; Kjellman, N.I.; et al. Slight Steroid-Sparing Effect of Intravenous Immunoglobulin in Children and Adolescents with Moderately Severe Bronchial Asthma. Allergy 1994, 49, 413-420.
81. Spahn, J.D.; Leung, D.Y.; Chan, M.T.; et al. Mechanisms of Glucocorticoid Reduction in Asthmatic Subjects Treated with Intravenous Immunoglobulin. J. Allergy Clin. Immunol. 1999, 103, 421-426.
82. Sigman, K.; Ghibu, F.; Sommerville, W.; et al. Intravenous Immunoglobulin Inhibits IgE Production in Human B Lymphocytes. J. Allergy Clin. Immunol. 1998, 102 (3), 421-427.
83. Vrugt, B.; Wilson, S.; van Velzen, E.; et al. Effects of High Dose Intravenous Immunoglobulin in Two Severe Corticosteroid Insensitive Asthmatic Children. Thorax 1997, 52, 662-664.
84. Niggemann, B.; Leupold, W.; Schuster, A.; et al. Prospective, Double-Blind, Placebo-Controlled, Multicentre Study on the Effect of High-Dose, Intravenous Immunoglobulin in Children and Adolescents with Severe Bronchial Asthma. Clin. Exp. Allergy 1998, 28, 205-210.
85. Salmun, L.M.; Barlau, I.; Wolf, H.M.; et al. Effect of Intravenous Immunoglobulin on Steroid Consumption in Patients with Severe Asthma: A Double-Blind, Placebo-Controlled, Randomised Trial. J. Allergy Clin. Immunol. 1999, 103, 810-815.
86. Kishimaya, J.L.; Valacer, D.; Cunningham-Rundles, C.; et al. A Multicenter, Randomised, Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma. Clin. Immunol. 1999, 91 (2), 126-133.
87. Marin, M.G. Low-Dose Methotrexate Spares Steroid Usage in Steroid-Dependent Asthmatic Patients: A Meta-Analysis. Chest 1997, 112, 29-33.
88. Aaron, S.D.; Dales, R.E.; Pham, B. Management of Steroid-Dependent Asthma with Methotrexate: A Meta-Analysis of Randomised Clinical Trials. Respir. Med. 1998, 92, 1059-1065.
89. Stempel, D.A.; Lammert, J.; Mullarkey, M.F. Use of Methotrexate in the Treatment of Steroid-Dependent Adolescent Asthmatics. Ann. Allergy. 1991, 67, 346-348.
90. Guss, S.; Portnoy, J. Methotrexate Treatment of Severe Asthma in Children. Pediatrics 1992, 89, 635-639.
91. Sole, D.; Costa-Carvalho, B.T.; Soares, F.J.; et al. Methotrexate in the Treatment of Corticodependent Asthmatic Children. J. Investing. Allergol. Clin. Immunol. 1996, 6, 126-130.
92. Norman, P.S. Is There a Role for Immunotherapy in the Treatment of Asthma? Yes. Am. J. Respir. Crit. Care Med. 1996, 154, 1225-1226.
93. Barnes, P.J. Is There a Role for Immunotherapy in the Treatment of Asthma? No. Am. J. Respir. Crit. Care Med. 1996, 154, 1227-1228.
94. Abramson, M.J.; Puy, R.M.; Weiner, J.M. Is Allergen Immunotherapy Effective in Asthma? A Meta-Analysis of Randomised Controlled Trials. Am. J. Respir. Crit. Care Med. 1995, 151, 969-974.
95. Bousquet, J.; Michel, F.-B. Specific Immunotherapy in Asthma: Is It Effective? J. Allergy Clin. Immunol. 1994, 94, 1-11.
96. Creticos, P.S.; Reed, C.E.; Norman, P.S.; et al. Ragweed Immunotherapy in Adult Asthma. N. Engl. J. Med. 1996, 334, 501-506.
97. Adkinson, N.F.; Eggleston, P.A.; Eney, D.; et al. A Controlled Trial of Immunotherapy for Asthma in Allergic Children. N. Engl. J. Med. 1997, 336, 324-331.
98. Muranaka, M.; Nakajima, K.; Suzuki, S. Bronchial Responsiveness to Acetylcholine in Patients with Bronchial Asthma After Long-Term Treatment with Gold Salt. J. Allergy Clin. Immunol. 1981, 67, 350-356.
99. Muranaka, M.; Miyamoto, T.; Shida, T.; et al. Gold Salt in the Treatment of Bronchial Asthma: A Double Blind Study. Ann. Allergy 1978, 40, 132-137.
100. Nierop, G.; Gijzel, W.P.; Bel, E.H.; et al. Auranofin in the Treatment of Steroid Dependent Asthma: A Double Blind Study. Thorax 1992, 47, 349-354.
101. Bernstein, I.L.; Bernstein, D.I.; Dubb, J.W.; et al. A Placebo-Controlled Multicenter Study of Auranofin in the Treatment of Patients with Corticosteroid-Dependent Asthma. J. Allergy Clin. Immunol. 1996, 98, 317-324.
102. Ball, B.D.; Hill, M.R.; Brenner, M.; et al. Effect of Low-Dose Troleandomycin on Glucocorticoid Pharmacokinetics and Airway Hyperresponsiveness in Severely Asthmatic Children. Ann. Allergy. 1990, 65, 37-45.
103. Zeiger, R.S.; Schatz, M.; Sperling, W.; et al. Efficacy of Troleandomycin in Outpatients with Severe, Corticosteroid-Dependent Asthma. J. Allergy Clin. Immunol. 1980, 66, 438-446.
104. Hahn, D.L.; Bukstein, D.; Luskin, A.; et al. Evidence for Chlamydia Pneumoniae Infection in Steroid-Dependent Asthma. Ann. Allergy Asthma Immunol. 1998, 80, 45-49.
105. Berlow, B.A.; Liebhaber, M.I.; Dyer, Z.; et al. The Effect of Dapsone in Steroid Dependent Asthma. J. Allergy Clin. Immunol. 1991, 87, 710-715.
106. Charous, B.L. Open Study of Hydroxychloroquine in the Treatment of Severe Symptomatic or Corticosteroid-Dependent Asthma. Ann. Allergy. 1990, 65, 53-58.
107. Roberts, J.A.; Gunneberg, A.; Elliot, J.A.; et al. Hydroxychloroquine in Steroid Dependent Asthma. Pulm. Pharmacol. 1988, 1, 59-61.
108. Rabinovitch, N.; Gelfand, E.W. New Approaches to the Treatment of Childhood Asthma. Curr. Opin. Pediatr. 1998, 10, 243-249.
109. Milgrom, H.; Fick, R.B.; Su, J.Q.; et al. Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody. N. Engl. J. Med. 1999, 341, 1966-1973.
110. Hatzelmann, A.; Tenor, H.; Schudt, C. Differential Effects of Non-Selective and Selective Phosphodiesterase Inhibitors on Human Eosinophil Functions. Br. J. Pharmacol. 1995, 114, 821-831.
111. Sullivan, P.; Bekir, S.; Jaffar, Z.; et al. Anti-Inflammatory Effects of Low-Dose Oral Theophylline in Atopic Asthma. Lancet 1994, 343, 1006-1008.
112. Barnes, P.J.; Pederson, S.; Busse, W.W. Efficacy and Safety of Inhaled Corticosteroids: New Developments. Am. J. Respir. Crit. Care Med. 1998, 157, S1-S53.
113. Reiser, J.; Warner, J.O. The Value of Participating in an Asthma Trial. Lancet 1985, 1, 206-207.